Black Diamond Therapeutics, Inc.BDTXNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank77
3Y CAGR+74.4%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+74.4%/yr
Quarterly compound
Percentile
P77
Within normal range
vs 3Y Ago
5.3x
Strong expansion
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 6.52% |
| Q3 2025 | 18.20% |
| Q2 2025 | -124.61% |
| Q1 2025 | 398.39% |
| Q4 2024 | -0.80% |
| Q3 2024 | 18.08% |
| Q2 2024 | -9.31% |
| Q1 2024 | 2.92% |
| Q4 2023 | 13.15% |
| Q3 2023 | -19.87% |
| Q2 2023 | 7.09% |
| Q1 2023 | 1.33% |
| Q4 2022 | 1.23% |
| Q3 2022 | 4.53% |
| Q2 2022 | 9.76% |
| Q1 2022 | 1.54% |
| Q4 2021 | 26.25% |
| Q3 2021 | -1.87% |
| Q2 2021 | -13.03% |
| Q1 2021 | -32.48% |
| Q4 2020 | -25.45% |
| Q3 2020 | -22.97% |
| Q2 2020 | -16.69% |
| Q1 2020 | -24.51% |
| Q4 2019 | -26.95% |
| Q3 2019 | -16.42% |
| Q2 2019 | -82.22% |
| Q1 2019 | -26.10% |
| Q4 2018 | -30.23% |
| Q3 2018 | -32.94% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |